UiPath holder plans $21.8M stock sale via Morgan Stanley

UiPath, Inc. (PATH) has a notice of proposed resale of restricted common stock under Rule 144 by ICEVULCAN Investments Limited.

Rhea-AI Filing Summary

UiPath, Inc. (PATH) has a notice of proposed resale of restricted common stock under Rule 144 by ICEVULCAN Investments Limited. The notice covers 1,402,347 shares of common stock, to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $21,848,566.26.

The shares were originally acquired on April 21, 2021 as “Founders Shares” from UiPath, Inc. Total UiPath common shares outstanding are reported as 453,429,560. The proposed sale date referenced in the notice is August 19, 2026, and the form is signed by Daniel Dines.

Key Figures

Shares to be sold: 1,402,347 shares Aggregate market value: $21,848,566.26 Shares outstanding: 453,429,560 shares +2 more

5 metrics

Shares to be sold 1,402,347 shares Common stock covered by the Rule 144 notice

Aggregate market value $21,848,566.26 Value of 1,402,347 UiPath common shares in the notice

Shares outstanding 453,429,560 shares UiPath common stock outstanding as reported in the notice

Acquisition date of shares 04/21/2021 Date the founders shares were acquired from UiPath, Inc.

Proposed sale date reference 08/19/2026 Date associated with the proposed sale of the shares

Key Terms

Rule 144, Founders Shares, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founders Shares financial

"04/21/2021 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

aggregate market value financial

"| 1402347 | 21848566.26 | 453429560 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for UiPath, Inc. (PATH)?

The filing reports a planned resale of 1,402,347 UiPath common shares under Rule 144 by ICEVULCAN Investments Limited. It is a regulatory notice of potential sales, not an issuance of new shares by UiPath.

How many UiPath (PATH) shares are covered by this Rule 144 notice?

The notice covers 1,402,347 shares of UiPath common stock. These shares are proposed to be sold through Morgan Stanley Smith Barney LLC and were originally acquired as founders shares on April 21, 2021.

What is the market value of the UiPath (PATH) shares in this Form 144?

The filing lists an aggregate market value of $21,848,566.26 for the 1,402,347 UiPath common shares. This figure reflects the value used for the Rule 144 notice at the time of the filing.

Who is selling UiPath (PATH) shares under this Form 144?

The person for whose account the securities are to be sold is ICEVULCAN Investments Limited. The Form 144 is signed by Daniel Dines and identifies Morgan Stanley Smith Barney LLC as the broker handling the sale.

When were the UiPath (PATH) shares acquired and when may they be sold?

The shares were acquired on April 21, 2021 as “Founders Shares” from UiPath, Inc. The notice references August 19, 2026 in connection with the proposed sale of the 1,402,347 shares.

How many UiPath (PATH) shares are outstanding according to this filing?

The filing reports that UiPath has 453,429,560 shares of common stock outstanding. This figure is provided as context in the Rule 144 notice alongside the 1,402,347 shares covered by the proposed resale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/19/2026 - 04:38 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001855767
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UiPath, Inc.
SEC File Number	001-40348
Address of Issuer	One Vanderbilt Avenue, 60th Floor New York NEW YORK 10017
Phone	8444320455
Name of Person for Whose Account the Securities are To Be Sold	ICEVULCAN INVESTMENTS LIMITED
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1402347	21848566.26	453429560	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/21/2021	Founders Shares	Issuer			1402347	04/21/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Dines
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)